Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 235-527-7 | CAS number: 12262-58-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
- Endpoint:
- basic toxicokinetics, other
- Remarks:
- expert statement
- Type of information:
- other: expert statement
- Adequacy of study:
- supporting study
- Conclusions:
- Due to lack of quantitative data, absorption rates of 100% are indicated for all three routes. This basically indicates that, although the absorption is probably low, there is likely no significant difference expected in absorption between oral, dermal and inhalation route. Available studies (readily biodegradable, low log kow 1.2) do not indicate a concern for bioaccumulation.
Low bioaccumulation potential
Absorption: 100% by all three routes - Executive summary:
1. Physical-chemical properties
The test substance, cyclohexanone peroxide CAS 12262-58-7 is a multi-constituent (equilibrium mixture of cyclohexyl based organic peroxides: 2408-01-7, monoperoxy monomer; 2407-94-5, monoperoxy dimer; 78-18-2, diperoxy dimer; 2699-12-9, triperoxy dimer; 2699-11-8, diperoxy monomer) and has a molecular weight range of 132.2 – 262.3 g/mole. It is a clear liquid.
The substance is classified as Organic peroxide type D; liquid, Division 5.2; UN 3105.
Organic peroxides are thermally unstable substances, which may undergo self-accelerating decomposition. The self-accelerating decomposition temperature (SADT) is 55°C. The maximum storage temperature is 25°C and the minimum is -10°C.
The major thermal decomposition products are: carbon dioxide, cyclohexanone and water.
The substance has no melting point or boiling point due to the SADT. The vapour pressure is 1.90 KPa at 20°C which is in the low range.
The octanol-water partition coefficient is low at is 1.2 and the water solubility is 9.3 g/L.
2. Data from acute toxicity studies and irritation studies
The oral LD50 forcyclohexanone peroxideis 1242 mg/kg bw. The inhalation LD50 >5ppm and there is no acute dermal study. Further acute toxicity testing is not possible due the corrosive nature of the substance. Since dermal absorption is not quantitatively evaluated, 100% is assumed as worst case assumption.
3. Data from repeated dose toxicity studies
Oral:
In an OECD422 the test item was administered by gavage to three groups, each of twelve male and twelve female Wistar Han™:RccHan™:WIST strain rats, for approximately six weeks to males and up to eight weeks to females including a two week pre-pairing phase, pairing, gestation and early lactation, at dose levels of 30, 100 or 200 mg/kg bw/day. A control group of twelve males and twelve females was dosed with vehicle alone (Polyethylene glycol 400).
There were no unscheduled deaths considered to be related to the systemic toxicity of the test item. There were four premature decedents during the course of the study, two each from the 100 or 200 mg/kg bw/day dose groups; one female from either dose group was found dead whilst the other was killedin extremis. Three of these animals showed clinical signs of respiratory distress which correlated with microscopic changes in the trachea with the change considered to have been a major factor in the death of one female from each dose group; these clinical signs and microscopic changes and, thus the deaths, were considered likely to be due to an irritant nature of the test item and not an indication of its systemic toxicity. Microscopic examination of the tissues from the remaining female treated with 200 mg/kg bw/day showed marked inflammatory change in the reproductive tract and secondary lymphoid/cellular depletion and it was deemed likely that these changes were a result of parturition and unrelated to administration of the test item.
At 200 mg/kg bw/day, individual animals of either sex surviving to the scheduled necropsy showed a few instances of noisy respiration mainly during the latter half of the treatment period with one of the males also showing noisy/laboured respiration and decreased respiratory rate on Day 35. These were deemed likely to be due to an irritant nature of the test item and not an indication of its systemic toxicity. Of the four premature decedent animals, three showed inflammatory changes in the trachea with the change considered to have been a major factor in the premature death of two of the animals. These changes are unusual, correlated with the respiratory clinical sign noted and may be indicative of reflux after gavage dosing and thus related to test item irritancy rather than its toxicity.
No other treatment-related effects were detected in animals of either sex at any dose level.
Based on the available data, the premature deaths of three females were considered likely due to an irritant nature of the test item rather than an indication of its systemic toxicity and, as such the ‘No Observed Adverse Effect Level’ (NOAEL) for systemic toxicity, was considered to be 200 mg/kg bw/day within the confines of this study.
There was no effect of treatment on mating performance, fertility, gestation length or any of the maternal and offspring parameters measured and The ‘No Observed Effect Level’ (NOEL) for reproductive toxicity, within the confines of this screening study, was considered to be 200 mg/kg bw/day.
Inhalation:
There are no data from repeated dose studies via the inhalation route. One acute inhalation study is available in which a low concentration, based on vapor formation at ambient temperature, was tested. LD50 is >5.0 ppm (based on the vapor, >0.029 mg/l). No irritation was observed in this study. The substance is corrosive to skin and eyes and further testing is not foreseen. The substance is a liquid with a low vapour pressure (1.90 KPa at 20°C).
Dermal:
No data from repeated dose studies via dermal route. The substance is corrosive to skin and eyes and further testing is not foreseen.
3. Absorption, distribution, metabolism, excretion
No adme data are is available and therefore 100% adsorption is assumed for all routes.Available studies (readily biodegradable, low log kow 1.2) do not indicate a concern for bioaccumulation.
Reference
Description of key information
Due to lack of quantitative data, absorption rates of 100% are indicated for all three routes. This basically indicates that, although the absorption is probably low, there is likely no significant difference expected in absorption between oral, dermal and inhalation route. Available studies (readily biodegradable, low log kow) do not indicate a concern for bioaccumulation.
Key value for chemical safety assessment
- Bioaccumulation potential:
- low bioaccumulation potential
- Absorption rate - oral (%):
- 100
- Absorption rate - dermal (%):
- 100
- Absorption rate - inhalation (%):
- 100
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.